- $2.40bn
- $3.54bn
- $491.98m
- 38
- 42
- 33
- 30
Annual income statement for Alvotech SA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 20-F | 20-F | 20-F |
Standards: | IFRS | — | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 69.4 | 39.7 | 85 | 93.4 | 492 |
Cost of Revenue | |||||
Gross Profit | — | — | 20.9 | -67.5 | 307 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 207 | 123 | 459 | 470 | 492 |
Operating Profit | -138 | -83.7 | -374 | -376 | 0.266 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -292 | -149 | -552 | -651 | -218 |
Provision for Income Taxes | |||||
Net Income After Taxes | -170 | -102 | -514 | -552 | -232 |
Net Income Before Extraordinary Items | |||||
Net Income | -170 | -102 | -514 | -552 | -232 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -170 | -102 | -514 | -552 | -232 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -5.4 | -0.789 | -2.5 | -2.36 | -0.697 |